JBAVX
Price
$31.76
Change
+$0.33 (+1.05%)
Updated
Oct 13 closing price
Net Assets
6.09B
RLBFX
Price
$38.98
Change
+$0.57 (+1.48%)
Updated
Oct 13 closing price
Net Assets
261.29B
Interact to see
Advertisement

JBAVX vs RLBFX

Header iconJBAVX vs RLBFX Comparison
Open Charts JBAVX vs RLBFXBanner chart's image
JHancock Balanced R5
Price$31.76
Change+$0.33 (+1.05%)
VolumeN/A
Net Assets6.09B
American Funds American Balanced R5
Price$38.98
Change+$0.57 (+1.48%)
VolumeN/A
Net Assets261.29B
JBAVX vs RLBFX Comparison Chart in %
View a ticker or compare two or three
VS
JBAVX vs. RLBFX commentary
Oct 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JBAVX is a Buy and RLBFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBFX has more cash in the bank: 261B vs. JBAVX (6.09B). RLBFX pays higher dividends than JBAVX: RLBFX (2.00) vs JBAVX (1.83). JBAVX was incepted earlier than RLBFX: JBAVX (17 years) vs RLBFX (23 years). JBAVX (0.68) is less costly to investors than RLBFX (0.29). JBAVX is a more actively managed with annual turnover of: 67.00 vs. RLBFX (44.00). JBAVX has a lower initial minimum investment than RLBFX: JBAVX (0) vs RLBFX (250). JBAVX annual gain was more profitable for investors over the last year : 9.68 vs. RLBFX (8.89). JBAVX (44.86) and RLBFX (43.33) have equivalent 5 years return.
JBAVXRLBFXJBAVX / RLBFX
Total Expense Ratio0.670.29231%
Annual Report Gross Expense Ratio0.680.29234%
Fund Existence17 years23 years-
Gain YTD11.13514.59676%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets6.09B261B2%
Annual Yield % from dividends1.832.0092%
Returns for 1 year9.688.89109%
Returns for 3 years54.6254.62100%
Returns for 5 years44.8643.33104%
Returns for 10 years97.1278.27124%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CSHCX8.280.07
+0.85%
NYLI Cushing® MLP Premier Class C
FHCIX66.53N/A
N/A
Fidelity Advisor Health Care I
JUEQX27.44N/A
N/A
JPMorgan US Equity R4
TAAGX13.73N/A
N/A
Timothy Plan Small/Mid Cap Growth Cl A
AWYIX61.18N/A
N/A
CIBC Atlas Equity Income Institutional